为新冠肺炎寻找抗炎治疗的合适时机。 - Suppr

Suppr

超能文献

Finding the right time for anti-inflammatory therapy in COVID-19.

作者信息

de Simone Giovanni, Mancusi Costantino

机构信息

Department of Advanced Biomedical Science, Federico II University of Naples, Naples, Italy.

出版信息

Int J Infect Dis. 2020 Dec;101:247-248. doi: 10.1016/j.ijid.2020.09.1454. Epub 2020 Oct 1.

DOI:10.1016/j.ijid.2020.09.1454

PMID:33011285

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7528747/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1455/7528747/4a41b16c7be9/gr1_lrg.jpg

相似文献

Finding the right time for anti-inflammatory therapy in COVID-19.为新冠肺炎寻找抗炎治疗的合适时机。

Int J Infect Dis. 2020 Dec;101:247-248. doi: 10.1016/j.ijid.2020.09.1454. Epub 2020 Oct 1.

Interleukin 6 levels after tocilizumab administration in transplant recipients with COVID-19.托珠单抗治疗新型冠状病毒肺炎移植受者后的白细胞介素6水平

Kidney Int. 2020 Oct;98(4):1054. doi: 10.1016/j.kint.2020.06.025. Epub 2020 Jul 8.

Cytokine release syndrome in severe COVID-19.重症新型冠状病毒肺炎中的细胞因子释放综合征

Science. 2020 May 1;368(6490):473-474. doi: 10.1126/science.abb8925. Epub 2020 Apr 17.

Interleukin-6 receptor antagonist therapy to treat SARS-CoV-2 driven inflammatory syndrome in a kidney transplant recipient.白细胞介素-6受体拮抗剂疗法治疗肾移植受者中由SARS-CoV-2驱动的炎症综合征。

Transpl Infect Dis. 2020 Aug;22(4):e13326. doi: 10.1111/tid.13326. Epub 2020 Jun 5.

Anakinra in COVID-19 therapy: what have we learned from adult-onset Still's disease?阿那白滞素在新冠病毒病治疗中的应用：我们从成人斯蒂尔病中学到了什么？

Clin Exp Rheumatol. 2020 May-Jun;38(3):579. Epub 2020 May 27.

Early identification of COVID-19 cytokine storm and treatment with anakinra or tocilizumab.早期识别 COVID-19 细胞因子风暴并使用阿那白滞素或托珠单抗治疗。

Int J Infect Dis. 2020 Oct;99:291-297. doi: 10.1016/j.ijid.2020.07.081. Epub 2020 Aug 6.

Lessons from the Italian COVID-19 frontline.来自意大利新冠疫情前线的经验教训。

Minerva Med. 2020 Aug;111(4):303-305. doi: 10.23736/S0026-4806.20.06664-1.

Biomarker-guided application of low-dose anakinra in an acute respiratory distress syndrome patient with severe COVID-19 and cytokine release syndrome.生物标志物指导下低剂量阿那白滞素在一名患有重症 COVID-19 和细胞因子释放综合征的急性呼吸窘迫综合征患者中的应用。

Scand J Rheumatol. 2020 Sep;49(5):414-416. doi: 10.1080/03009742.2020.1789734. Epub 2020 Sep 11.

Mast cells activated by SARS-CoV-2 release histamine which increases IL-1 levels causing cytokine storm and inflammatory reaction in COVID-19.SARS-CoV-2 激活的肥大细胞释放组织胺，增加白细胞介素-1 水平，导致 COVID-19 中的细胞因子风暴和炎症反应。

J Biol Regul Homeost Agents. 2020;34(5):1629-1632. doi: 10.23812/20-2EDIT.

IL-6 trans-signaling induces plasminogen activator inhibitor-1 from vascular endothelial cells in cytokine release syndrome.白细胞介素-6 转导信号诱导细胞因子释放综合征中的血管内皮细胞产生纤溶酶原激活物抑制剂-1。

Proc Natl Acad Sci U S A. 2020 Sep 8;117(36):22351-22356. doi: 10.1073/pnas.2010229117. Epub 2020 Aug 21.

引用本文的文献

Aged garlic extract major constituent S-1-propenyl-l-cysteine inhibits proinflammatory mRNA expression in bronchial epithelial IB3-1 cells exposed to the BNT162b2 vaccine.aged大蒜提取物的主要成分S-1-丙烯基-L-半胱氨酸可抑制暴露于BNT162b2疫苗的支气管上皮IB3-1细胞中的促炎mRNA表达。

Exp Ther Med. 2025 Jun 10;30(2):153. doi: 10.3892/etm.2025.12903. eCollection 2025 Aug.

Aged Garlic Extract (AGE) and Its Constituent S-Allyl-Cysteine (SAC) Inhibit the Expression of Pro-Inflammatory Genes Induced in Bronchial Epithelial IB3-1 Cells by Exposure to the SARS-CoV-2 Spike Protein and the BNT162b2 Vaccine. aged garlic extract (AGE)及其成分S-烯丙基半胱氨酸（SAC）可抑制支气管上皮IB3-1细胞因暴露于SARS-CoV-2刺突蛋白和BNT162b2疫苗而诱导的促炎基因表达。

Molecules. 2024 Dec 16;29(24):5938. doi: 10.3390/molecules29245938.

The efficacy of corticosteroids therapy in patients with moderate to severe SARS-CoV-2 infection: a multicenter, randomized, open-label trial.糖皮质激素治疗中重度 SARS-CoV-2 感染患者的疗效：一项多中心、随机、开放标签试验。

Respir Res. 2021 Sep 15;22(1):245. doi: 10.1186/s12931-021-01833-6.

Sulforaphane inhibits the expression of interleukin-6 and interleukin-8 induced in bronchial epithelial IB3-1 cells by exposure to the SARS-CoV-2 Spike protein.萝卜硫素可抑制 SARS-CoV-2 刺突蛋白作用于支气管上皮 IB3-1 细胞后诱导的白细胞介素-6 和白细胞介素-8 的表达。

Phytomedicine. 2021 Jul;87:153583. doi: 10.1016/j.phymed.2021.153583. Epub 2021 May 4.

Mechanistic and Therapeutic Implications of Extracellular Vesicles as a Potential Link Between Covid-19 and Cardiovascular Disease Manifestations.细胞外囊泡作为新冠病毒与心血管疾病表现之间潜在联系的机制及治疗意义

Front Cell Dev Biol. 2021 Feb 11;9:640723. doi: 10.3389/fcell.2021.640723. eCollection 2021.

Successful use of mild therapeutic hypothermia as compassionate treatment for severe refractory hypoxemia in COVID-19.成功应用轻度治疗性低体温作为 COVID-19 严重难治性低氧血症的同情治疗。

J Crit Care. 2021 Jun;63:260-263. doi: 10.1016/j.jcrc.2021.01.008. Epub 2021 Jan 23.

An integrative look at SARS‑CoV‑2 (Review).综合分析 SARS-CoV-2（综述）

Int J Mol Med. 2021 Feb;47(2):415-434. doi: 10.3892/ijmm.2020.4828. Epub 2020 Dec 22.

本文引用的文献

Early identification of COVID-19 cytokine storm and treatment with anakinra or tocilizumab.早期识别 COVID-19 细胞因子风暴并使用阿那白滞素或托珠单抗治疗。

Int J Infect Dis. 2020 Oct;99:291-297. doi: 10.1016/j.ijid.2020.07.081. Epub 2020 Aug 6.

Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19.羟氯喹或联合阿奇霉素治疗轻中度 COVID-19。

N Engl J Med. 2020 Nov 19;383(21):2041-2052. doi: 10.1056/NEJMoa2019014. Epub 2020 Jul 23.

Dexamethasone in Hospitalized Patients with Covid-19.地塞米松在 COVID-19 住院患者中的应用。

N Engl J Med. 2021 Feb 25;384(8):693-704. doi: 10.1056/NEJMoa2021436. Epub 2020 Jul 17.

COVID-19 illness in native and immunosuppressed states: A clinical-therapeutic staging proposal.新冠病毒疾病在自然状态和免疫抑制状态下：一项临床治疗分期建议。

J Heart Lung Transplant. 2020 May;39(5):405-407. doi: 10.1016/j.healun.2020.03.012. Epub 2020 Mar 20.

COVID-19: Timing is Important.新型冠状病毒肺炎：时机很重要。

Eur J Intern Med. 2020 Jul;77:134-135. doi: 10.1016/j.ejim.2020.04.019. Epub 2020 Apr 13.

Dynamic balance of pro- and anti-inflammatory signals controls disease and limits pathology.促炎和抗炎信号的动态平衡控制着疾病并限制了病理。

Immunol Rev. 2018 Sep;285(1):147-167. doi: 10.1111/imr.12671.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验